Skip to main content
logo
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
11.13
-0.26 (-2.28%)
Mar 19, 2026, 2:55 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Active Pharmaceutical Ingredient (API)
3.39B3.44B2.67B2.72B2.70B
Active Pharmaceutical Ingredient (API) Growth
-1.72%28.84%-1.77%0.77%-
Intersegment offset
-6.72B-5.88B---
Others
415.03M448.25M191.12M191.89M310.32M
Others Growth
-7.41%134.54%-0.40%-38.16%-
CDMO
1.03B968.26M1.08B813.10M797.39M
CDMO Growth
6.78%-10.68%33.32%1.97%-
Preparations
7.14B6.45B3.21B2.64B1.52B
Preparations Growth
10.80%100.85%21.69%73.20%-
Total
5.26B5.43B7.16B6.37B5.33B
Total Growth
-3.17%-24.14%12.48%19.38%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Foreign
--6.51B5.81B4.80B
Foreign Growth
--12.09%20.96%13.98%
China
--649.85M557.63M530.90M
China Growth
--16.54%5.04%28.77%
Hong Kong
7.20M18.10M---
Hong Kong Growth
-60.19%----
United States of America
1.43B1.28B---
United States of America Growth
11.96%----
Europe
2.37B2.62B---
Europe Growth
-9.28%----
Mainland China
339.16M397.84M---
Mainland China Growth
-14.75%----
Other Countries/Regions
1.11B1.12B---
Other Countries/Regions Growth
-1.11%----
Total
5.26B5.43B7.16B6.37B5.33B
Total Growth
-3.17%-24.14%12.48%19.38%15.30%
Source: S&P Global Market Intelligence.